This post was written by Annie Lincoln, Ph.D. Student within the Cancer Prevention Group at King’s College London. Annie is interested in improved colorectal cancer […]
James DeGregori is a Professor of Biochemistry and Molecular Genetics at the University of Colorado. His lab seeks to understand how carcinogenic conditions promote cancer […]
Paul Pharoah is Professor of Cancer Epidemiology at the University of Cambridge, where he leads research on the molecular pathology of breast and ovarian cancer […]
The results of the BEST3 trial have just been published and the findings have exceeded even our most optimistic expectations. This trial showed that the […]
This blog was written by Mairéad Lyons. Mairéad is a Senior Consultant to YouScreen the HPV Self-Sampling study. She has been working in healthcare for […]
Following the publication of the NELSON trial earlier this month, Dr Rintoul, University Reader in Thoracic Oncology at the University of Cambridge and Honorary Respiratory […]
Following a high-profile article calling for a change in guidelines to make it easier for African Americans to be eligible for lung cancer screening, Prof […]
We are celebrating the end of recruitment for the BEST3 Cytosponge™ Trial. In this post the BEST3 team in London and Cambridge tell us about this […]
In this post Hilary Robbins, Scientist at the International Agency for Research on Cancer (IARC), discuses the art of communicating scientific information accurately. Whether or […]
In this post Dr Emma Crosbie, Senior Lecturer & Honorary Consultant Gynaecological Oncologist, tells us about the first ever workshop to develop international standards of […]
Blog written by Rhian Gabe, Reader in Clinical Trials at Hull York Medical School. Rhian is the statistician for the Yorkshire Lung Screening Trial (YLST) […]
Copyright © 2021 | WordPress Theme by MH Themes
